Cleveland Clinic Incontinence Score
Study	Group	Measure	Patients	Baseline	Three months	'Off' period	'On' period	Change (%)	Follow‐up	Notes
Kahlke 2015#		Mean (SD)	14	16 (4.6)		14.6 (4.6)	8.7 (3.6)	‐5.9 (‐40%)	6.4 (3.3)	p<0.05
Kahlke 2015#
Kahlke 2015#
Leroi 2005#	Whole group	Median (range)	Baseline: 23 3 months: 16 'Off' period: 15 'On' period: 17	16 (8 to 20)	9 (0 to 19)	10.5 (4 to 17)	8.5 (3 to 18)	‐2 (‐19%)	Not reported for whole group	1. Cleveland Clinic scores are reported for whole group. 2. The score ranges from 0 (normal continence) to 20 (maximum incontinence)
Leroi 2005#	Group of 19 who chose 'on' following the crossover period	Median (range)	Baseline: 18 3 months: 13 'Off' period: 12 'On' period: 14 Follow‐up: 18	16 (8 to 20)	8 (0 to 15)	10 (4 to 17)	8 (3 to 15)	‐2 (‐20%)	10 (3 to 17)	1. P < 0.05: 3 months, 'off' period, 'on' period, follow‐up versus baseline.
Leroi 2005#	Group of 5 who chose 'off' following the crossover period	Median (range)	Baseline: 5 3 months: 3 'Off' period: 3 'On' period: 3 Follow‐up: 3	16 (12 to 20)	14 (9 to 19)	15 (11 to 15)	15 (14 to 18)	0	13 (11 to 18)
Thin 2015	PTNS group	Mean±SD	16	15.1 ± 2.7	11.7 ± 4.4			‐3 (‐ 20%)	12.1 ± 5.2	Follow‐up was at 6 months. % change is reported as the difference between baseline and at 6 months.
Thin 2015	SNS group	Mean±SD	15	16.3 ± 3.3	10.0 ± 5.3			‐7.2(‐44%)	9.1 ± 5.4	Follow‐up was at 6 months. % change is reported as the difference between baseline and at 6 months.
Thin 2015
Tjandra 2008	Control group	Mean±SD	60	15.2±1.6	12.1±2.1	14.1+1.9		‐1.1 (‐7%)	14.1±1.9	p > 0.05 at 3 months and 12 months compared with baseline. Follow‐up was at 12 months. % change is reported as the difference between baseline and at 12 months.
Tjandra 2008	SNS group	Mean±SD	53	16±1.3	1.1±1	1.2+1.8		‐14.8 (‐93%)	1.2±1.8	P < 0.0001 at all time points compared with baseline. Follow‐up was at 12 months. % change is reported as the difference between baseline and at 12 months.
Tjandra 2008